Daily as of 2 Nov 16:00 ET
- Price
- above both $553.15 vs 50 $523.32 / 200 $479.79
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 29 Jun 2026 · projected 12 bars out
VRTX | Vertex PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$553.15
-$5.73 (-1.03%)
Vertex Pharmaceuticals (VRTX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $558.88 vs 50 $474.63 / 200 $425.88
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 4 Apr 2022 · projected 22 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $530.76 vs 50 $516.29 / 200 $507.94
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 30 Jun 2026 · projected 25 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 30 Jun 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
| 29 Jun 2026 | 🟨Golden moderate | daily | 12 bars out | Not tested |
| 5 Jun 2026 | 💀Death moderate | daily | 25 bars out | 4 bar cross test |
| 8 Apr 2026 | 💀Death | 4-hour | 17 bars out | Not tested |
| 7 Jan 2026 | 🟨Golden moderate | daily | 27 bars out | 3 bar cross test |
About VRTX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$557M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge